D-乳酸在糖尿病及高血壓之研究

The Study of D-Lactate in Diabetes Mellitus and Hypertension Disease

謝綺雯(Chi-Wen Hsieh)

指導教授 ： 李仁愛

臺北醫學大學/藥學院/藥學研究所/碩士(2007年)

摘要

我們之前的研究，D-乳酸濃度可能可以作為偵測早期腎臟損傷之指標，考量這些結果，我們藉由偵測人類尿液中D-乳酸的含量來確認糖尿病與高血壓疾病與腎臟病變的相關性。
利用螢光衍生化試劑4-nitro-7-piperazino-2,1,3-benzoxadiazole (NBD-PZ) 將D-乳酸衍生化後，利用已建立之高效液相層析法，結合octadecylsilica管柱 (ODS)及掌性管柱 (amylose tris-3,5-dimethylphenylcarbamate coated on silica gel; Chiralpak AD-RH)，以高敏感度之螢光偵測方法，成功地檢測生物檢體中少量D-乳酸的濃度並發現對於生物檢體中微量的D-乳酸有好的分離效果。在分析方法確效中，以20 μL人類尿液為檢品時，其同日與異日間之準確度為91.59-112.96%，同日與異日間之精密度CV(%)為1.56-11.99%。
藉由上述的分析方法，偵測正常人(n = 13)與糖尿病、高血壓病人(n = 80)尿液中D-乳酸濃度，發現與正常人比對結果，病人尿液中D-乳酸的濃度有明顯上升(P<0.05)。另外，與正常人比對結果，病患在正常蛋白尿階段時，D-乳酸的濃度展現上升之趨勢(P<0.05)，再者，病患在微蛋白尿階段時，尿液中D-乳酸的濃度亦比病患在正常蛋白尿階段時要來的高。綜合上述實驗結果，建議尿液中D-乳酸的濃度可能可以作為偵測腎臟損傷的一個臨床前早期指標。

關鍵字

D-乳酸

並列摘要

In our previous study, D-lactate levels may be used as an indicator to screen for early stages of kidney injury. Considering these results, we determined of human urinary D-lactate to verify the relation to nephropathy with diabetes Mellitus and hypertension diseases.
D-lactate and L-lactate were simultaneously determined by means of a high-performance liquid chromatography (HPLC) with fluorescence detection. As a fluorescence reagent, 4-nitro-7-piperazino-2, 1, 3-benzoxadiazole (NBD-PZ) was employed for the fluorescence derivatization of lactate. The proposed HPLC system adopted both octylsilica (ODS) and chiral columns (amylose tris-3,5-dimethylphenylcarbamate coated on silica gel; Chiralpak AD-RH), which proved to give a sufficient enantiomeric separation of the lactate derivatives in the trace amount of biological sample. The accuracy values for the determination of D-lactate in 20 μL of human urine were 91.59-112.96%, and the intra- and inter-day precision values were within 1.56% and 11.99%, respectively.
The proposed HPLC method was applied to the urine of normal (n = 13) and diabetic and hypertension patients (n = 80), and significant increases in D-lactate excreted into urine were observed in patients (p<0.05). In addition, D-lactate concentrations showed a rising tendency from patients in normal albumin range compared with normal subject (p<0.05). Moreover, D-lactate levels significantly increased in patients with microalbuminuria as compared with normal subjects (p<0.05). These findings suggest that urinary D-lactate concentration may be offered the earliest subclinical sign of nephropathy.

並列關鍵字

D-lactate

參考文獻

1. Jacobson, E. Diabetic nephropathy. Dialysis and Transplantation 23, 616-621 (1994).

2. Ramachandran, A., Snehalatha, C. & Latha, E. Rising prevalence of NIDDM in an urban population in India. Diabetologia 40, 232-237 (1997).

3. American Diabetes Association. Position statement: diabetic nephropathy. Diabetes Care 26, S94-S98 (2003).

5. Tsilibary, E. Microvascular basement membranes in diabetes mellitus. The Journal of Pathology 200, 537-546 (2003).

6. Mogensen, CE., Christensen, CK. & Vittinghus, E. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes 32 Suppl 2, 64-78 (1983).